(2) Adjusted EBITDA is defined as net income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain items as ...

Net income attributable to Amedisys, Inc. of $61.0 million ... first quarter 2025 earnings release can be found on the Investor Relations page of our website. In light of the pending merger ...

Amedisys (NASDAQ:AMED) earlier ticked down 0.2% on a report that the Dept. of Justice has initially rejected the proposed divestiture buyers for its planned sale to UnitedHealth (NYSE:UNH). The ...

comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Amedisys performed in the just reported quarter ...

Amedisys (Nasdaq: AMED) announced on Thursday that the company has reached agreements to divest home health and hospice care centers to affiliates of the ...

Amedisys had its Relative Strength (RS) Rating upgraded from 62 to 71 Monday — a welcome improvement, but still shy of the 80 or higher score you look for. Please watch the video at Investors ...

AMEDISYS ($AMED) posted quarterly earnings results on Wednesday, April 23rd. The company reported earnings of $1.25 per share, beating estimates of $1.11 by $0.14 ...

Amedisys, Inc. (the “Company”) is a leading ... is routinely posted on and accessible on the Investor Relations subpage of our website, which is accessible by clicking on the tab labeled ...

BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025. Net service revenue increased ...

Amedisys is focused on delivering the care ... is routinely posted on and accessible on the Investor Relations subpage of our website, which is accessible by clicking on the tab labeled "Investors ...